Efficacy and safety of two dose regimens of rituximab for idiopathic membranous nephropathy
ObjectiveTo compare the clinical efficacy and safety of two regimens of rituximab (RTX) for idiopathic membranous nephropathy (IMN).MethodsA total of 79 IMN patients were recruited from December 01, 2019 to December 31, 2021. RTX two-dose regimen group (n=49): two infusions of 1g at 2-week intervals...
Gorde:
| Egile Nagusiak: | , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Chinês |
| Argitaratua: |
Editorial Department of Journal of Clinical Nephrology
2024-02-01
|
| Saila: | Linchuang shenzangbing zazhi |
| Gaiak: | |
| Sarrera elektronikoa: | http://www.lcszb.com/cn/article/doi/10.3969/j.issn.1671-2390.2024.02.001 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|